Non-practicing entities (NPEs) filed 58.7 percent of all patent infringement cases in 2012. That statistic, along with the rapid rise in NPE cases in recent years, has captured the attention of the legal and business communities, the press, the Federal Trade Commission, Congress, the President—just about anyone with a stake in innovation.
While the Internet and computer industries have been the primary NPE targets to date, NPEs now seem to be setting their sights on the medical device industry. And the medical industry would be wise to take note. Thus far, the NPE success rate in medical device patent litigation is higher than in other industries, and the median damages awarded to NPEs is over $20 million. Further, relatively large NPEs are aggregating medical device patents at a rapid clip.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
